Page last updated: 2024-08-22

platinum and elesclomol

platinum has been researched along with elesclomol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hasinoff, BB; Patel, D; Wu, X; Yadav, AA1
Ding, Y; Liu, B; Lu, L; Zheng, P; Zhou, C1

Reviews

1 review(s) available for platinum and elesclomol

ArticleYear
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
    Journal of experimental & clinical cancer research : CR, 2022, Sep-12, Volume: 41, Issue:1

    Topics: Copper; Humans; Hydrazines; Ionophores; Neoplasms; Platinum; Proteasome Inhibitors

2022

Other Studies

1 other study(ies) available for platinum and elesclomol

ArticleYear
Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
    Journal of inorganic biochemistry, 2013, Volume: 126

    Topics: Antineoplastic Agents; Ascorbic Acid; Cations, Divalent; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; Humans; Hydrazines; K562 Cells; Kinetics; Models, Molecular; Nickel; Oxidation-Reduction; Platinum; Reactive Oxygen Species; Trientine

2013